| The recent landscape of cancer research worldwide: a bibliometric and network analysis BP Cabral, MGD Fonseca, FB Mota Oncotarget 9 (55), 30474, 2018 | 78 | 2018 |
| Facebook in educational research: A bibliometric analysis RM Lopes, DJGS Faria, AA Fidalgo-Neto, FB Mota Scientometrics 111, 1591-1621, 2017 | 55 | 2017 |
| Mapping knowledge produced on problem-based learning between 1945 and 2014: A bibliometric analysis LA Pinho, FB Mota, MVF Conde, LA Alves, RM Lopes Scientific Research Publishing, 2015 | 32 | 2015 |
| 3D and 4D bioprinted human model patenting and the future of drug development F Mota, L Braga, L Rocha, B Cabral Nature Biotechnology 38 (6), 689-694, 2020 | 28 | 2020 |
| Mapping the dengue scientific landscape worldwide: a bibliometric and network analysis FB Mota, BPF Fonseca, AC Galina, RM Silva Memórias do Instituto Oswaldo Cruz 112 (5), 354-363, 2017 | 28 | 2017 |
| Mapping the tuberculosis scientific landscape among BRICS countries: a bibliometric and network analysis K Castor, FB Mota, RM da Silva, BP Cabral, EL Maciel, IN de Almeida, ... Memórias do Instituto Oswaldo Cruz 115, e190342, 2020 | 25 | 2020 |
| Articulação da indústria farmacêutica brasileira com o exterior: há evidências de especialização regressiva? FB Mota, JE Cassiolato, CAG Gadelha Cadernos de Saúde Pública 28, 527-536, 2012 | 20 | 2012 |
| Future of artificial intelligence applications in cancer care: a global cross-sectional survey of researchers BP Cabral, LAM Braga, S Syed-Abdul, FB Mota Current Oncology 30 (3), 3432-3446, 2023 | 18 | 2023 |
| Mapping the ‘dynamic capabilities’ scientific landscape, 1990-2015: A bibliometric analysis F Batista Mota, C Damasceno Pinto, J Paranhos, L Hasenclever COLLNET Journal of Scientometrics and Information Management 11 (2), 309-324, 2017 | 18 | 2017 |
| Diffusion of medical technology and equity in health in brazil: an exploratory analysis S Loureiro, B Simões, E Aragão, F Mota, H Moura, L Damasceno The European Journal of Development Research 19, 66-80, 2007 | 18 | 2007 |
| Future of genetic therapies for rare genetic diseases: what to expect for the next 15 years? LAM Braga, CG Conte Filho, FB Mota Therapeutic Advances in Rare Disease 3, 26330040221100840, 2022 | 13 | 2022 |
| Long term prevention and vector control of arboviral diseases: What does the future hold? BP Cabral, MGD Fonseca, FB Mota International Journal of Infectious Diseases 89, 169-174, 2019 | 13 | 2019 |
| Mapping the lab-on-a-chip patent landscape through bibliometric techniques FML Mendes, K Castor, R Monteiro, FB Mota, LFM Rocha World Patent Information 58, 101904, 2019 | 13 | 2019 |
| Probing expert opinions on the future of kidney replacement therapies B Pereira Cabral, JV Bonventre, F Wieringa, FB Mota Artificial Organs 45 (1), 79-87, 2021 | 12 | 2021 |
| Gene editing for treatment and prevention of human diseases: a global survey of gene editing-related researchers LFM Rocha, LAM Braga, FB Mota Human Gene Therapy 31 (15-16), 852-862, 2020 | 12 | 2020 |
| Anticipating new treatments for Cystic Fibrosis: a global survey of researchers B Cabral, V Terlizzi, O Laselva, C Conte Filho, F Mota Journal of Clinical Medicine 11 (5), 1283, 2022 | 10 | 2022 |
| The evolution of environmental metalloproteomics over the last 15 years through bibliometric techniques RA Hauser-Davis, RM Lopes, FB Mota, JC Moreira Ecotoxicology and environmental safety 140, 279-287, 2017 | 10 | 2017 |
| Futuro da pesquisa, desenvolvimento tecnológico e produção industrial de biofarmacêuticos no Brasil FB Mota, JE Cassiolato, CAG Gadelha Fundação Oswaldo Cruz. Instituto de Comunicação e Informação Científica e …, 2014 | 8 | 2014 |
| What is the future of lab-on-a-chip diagnostic devices? Assessing changes in experts’ expectations over time F Mota, LAM Braga, BPP Cabral, CG Conte Filho foresight 23 (6), 640-654, 2021 | 7 | 2021 |
| Early cancer diagnosis using lab-on-a-chip devices: a bibliometric and network analysis LA Maciel Braga, FB Mota COLLNET Journal of Scientometrics and Information Management 15 (1), 163-196, 2021 | 5 | 2021 |
